Marketer takes helm of Sanofi vaccines division

Share this article:
Wayne Pisano
Wayne Pisano

Sanofi Pasteur named Wayne Pisano president and CEO, replacing David Williams, who is retiring. He reports to Sanofi Aventis CEO Gerard Le Fur.

Pisano was previously SVP, global commercial operations and corporate strategy, tasked with directing the development and implementation of the company's commercial strategy.

He joined the company from Novartis as VP, US marketing in 1997 and the following year was promoted to SVP marketing and sales. In that role, he orchestrated a reorganization of the department and is credited with helping fuel a 180% jump in sales over his five years as the firm's top marketing exec.

He went on to serve as EVP, Sanofi Pasteur North America and SVP, global commercial operations, helping to establish the market positions of key products such as Fluzone, IPOL and Menactra and overseeing the firm's joint venture with Merck, Sanofi Pasteur MSD.

The firm won FDA approval of its H5N1 vaccine in April. Sanofi Pasteur products include Fluzone, Menactra, ActHIB, Adacel and Pentacel. Agencies include Saatchi & Saatchi Innovations, Integrated Communications, Deutsch and Publicis PR.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.